Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 60 entries
View as:

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Phase: N/A Priority: Normal
NCT ID: NCT02322866 Org: User:
Start: 12/03/14 End: 01/12/17 Due: 01/12/18

Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp

Phase: N/A Priority: Normal
NCT ID: NCT02838628 Org: User:
Start: 04/11/16 End: 12/22/17 Due: 12/22/18

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT05279131 Org: User:
Start: 06/28/22 End: 12/28/22 Due: 12/28/23

A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

Phase: N/A Priority: Normal
NCT ID: NCT06029257 Org: User:
Start: 11/14/23 End: 03/31/26 Due: 03/31/27

Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

Phase: N/A Priority: Normal
NCT ID: NCT01119313 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05916365 Org: User:
Start: 05/23/23 End: 04/30/26 Due: 04/30/27

Dermal Tolerability of Dapsone Gel in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02117752 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04339595 Org: User:
Start: 01/29/20 End: 07/31/20 Due: 07/31/21

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01974141 Org: User:
Start: 11/30/13 End: 10/31/14 Due: 10/31/15

Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05990725 Org: User:
Start: 11/20/23 End: 06/23/25 Due: 06/23/26

Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT01915784 Org: User:
Start: 07/31/13 End: 10/31/13 Due: 10/31/14

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01119339 Org: User:
Start: 07/31/10 End: 09/30/10 Due: 09/30/11

Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008

Phase: N/A Priority: Normal
NCT ID: NCT02955693 Org: User:
Start: 09/30/16 End: 11/30/16 Due: 11/30/17

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT00987246 Org: User:
Start: 06/30/08 End: 06/30/09 Due: 06/30/10

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01283698 Org: User:
Start: 01/31/11 End: 03/31/11 Due: 03/31/12

Photoallergy Potential of Dapsone Gel in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02117739 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06030076 Org: User:
Start: 09/06/23 End: 10/31/25 Due: 10/31/26

Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)

Phase: N/A Priority: Normal
NCT ID: NCT04322669 Org: User:
Start: 08/04/21 End: 11/04/21 Due: 11/04/22

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT06135415 Org: User:
Start: 12/21/23 End: 11/30/26 Due: 11/30/27

A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06200597 Org: User:
Start: 12/05/23 End: 03/11/25 Due: 03/11/26

A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

Phase: N/A Priority: Normal
NCT ID: NCT05811234 Org: User:
Start: 06/13/23 End: 10/01/24 Due: 10/01/25

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01726933 Org: User:
Start: 11/30/12 End: 11/30/15 Due: 11/30/16

Standardized sTudy With Almotriptan in eaRly Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT00725140 Org: User:
Start: 06/30/08 End: 07/31/09 Due: 07/31/10

A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting

Phase: N/A Priority: Normal
NCT ID: NCT06488170 Org: User:
Start: 04/04/24 End: 01/31/26 Due: 01/31/27

A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06815380 Org: User:
Start: 01/23/25 End: 03/31/29 Due: 03/31/30